baber/WOPTO huggingface dataset:
Patent NZ-212248-A (NZ)
Title: Inhibin hormone, antibodies thereto, production methods and compositions of each, animal treatments and assay methods
Inventor: BURGER HENRY GEORGE
IPC: C07K1/20
Filed: 1985-05-30
Abstract: A protein which satisfies all the biological criteria which are characteristic of inhibin has been isolated from a gonadal source. The purification and characterization of inhibin and the use of the purified material to raise antibodies, the use of inhibin and said antisera in a quantative radioimmunoassay, and application in vitro and in vivo of inhibin and antibody to inhibin, are described. There is provided a purified protein, inhibin characterized in that the apparent molecular weight as determined by SDS-PAGE is 56,000+/-1,000, the isoelectric point is in the range 6.9-7.3, and the protein can bind specifically to Concanavalin A-Sepharose. Moreover, the protein includes two subunits, characterized in that their apparent molecular weights as determined by SDS-PAGE are 44,000+/-3,000 and 14,000+/-2,000, respectively. Furthermore, the isoelectric point of the 44,000 molecular weight sub-unit is in the range of 6.0-7.0. In addition, the N-terminal amino acid sequence of the two subunits are described. With regard to the purified protein, inhibin, the protein can suppress follicle stimulating hormone (FSH) but not luteinizing hormone (EACH), thyroid stimulating hormone or prolactin in an in vitro bioassay system, and the protein can be labeled with radioactive iodine. In addition to the forgoing, there is also provided a method for isolating and purifying inhibin from mammalian ovarian follicular fluid, characterized by one or more gel permeation chromatography steps; reversed-phase high performance liquid chromatography steps; preparative polyacrylamide gel electrophoresis steps; and electrophoretic elution of the purified inhibin.
Patent NZ-212585-A (NZ)
Title: Aroyl-substituted thiazines and pharmaceutical compositions
Inventor: RENFROE H B
IPC: C07C323/22
Filed: 1985-01-28
Abstract: Compounds of the formula I,wherein Ar is pyridyl, phenyl or phenyl substituted by halogen, halo-C<sub>1-4</sub>-alkyl, C<sub>1-4</sub>alkoxy or carboxy-C<sub>1-4</sub>-alkyl, n is zero, one or two, R' is hydrogen, C<sub>1-4</sub>alkyl, heterocyclyl-C<sub>2-4</sub> alkyl, amino-C<sub>2-4</sub>alkyl, C<sub>1-4</sub>alkylamino-C<sub>2-4</sub>-alkyl, di-C<sub>1-4</sub> alkylamino-C<sub>2-4</sub>alkyl or C<sub>1-4</sub>alkanoyl, and R<sup>2</sup> is hydrogen, carboxy-C<sub>1-4</sub>alkyl or C<sub>1-4</sub>-alkoxy-carbonyl-C<sub>1-4</sub>-alkyl are disclosed as well as their preparation, pharmaceutical compositions containing the same and the use thereof as antirheumatic agents.
Patent NZ-212986-A (NZ)
Title: Coupling elements for ostomy bag
Inventor: STEER P L
IPC: A61F5/448
Filed: 1985-08-05
Abstract: An ostomy appliance having two interengaging coupling elements is described. One of the elements is an annular plate which includes an engaging member formed by two ribs which diverge from each other to define a V-formation. One of the ribs has a stepped formation on its distal region. The other coupling element has an annular channel having cooperating formation adapted to engage the stepped formation, thereby connecting the coupling elements.
Patent NZ-220406-A (NZ)
Title: Controlled release pharmaceutical with a core or matrix containing a c 10-18 alcohol and an acrylic resin
Inventor: OSHLACK B
IPC: A61K9/00
Filed: 1987-05-22
Abstract: The release of therapeutically active agents from controlled release bases is extended by using a combination of a higher aliphatic alcohol and an acrylic resin as the base material.
Patent NZ-224526-A (NZ)
Title: Paving stone moulding apparatus
Inventor: ROOK CORNELIS
IPC: B28B7/24
Filed: 1988-05-06
Abstract: Device for manufacturing stones, provided with a frame, with a mould (4) having boundary walls (6,7) defining moulding rooms inside the mould, with a stamp (5) movable up-and-down arranged above the mould (4) and with a table (2) arranged under the mould (4). Filling pieces (9) are movable between a first position, in which they are located under the mould and whereby, seen in top view, at least parts of the filling pieces (9) project from the walls for forming recesses, and a second position, in which the filling pieces are located beside the mould, seen in top view. Extensions (16) are connected to the filling pieces (9), said extensions (16) being movable forward and backward and co-operating with guide means (17) for guiding the filling pieces (9), whereby the extensions (16) project from the mould in the first position.
Patent NZ-227160-A (NZ)
Title: Preparation of (starch) polysaccharide by fermentation
Inventor: CROS PATRICK
IPC: C12P19/16
Filed: 1988-12-01
Abstract: Process for the production of biopolymers by fermentation of carbohydrates by means of microorganisms. The process consists in performing the fermentation in an aqueous nutrient medium containing starch as source of assimilable carbon in the presence of a saccharification enzyme. Application to the manufacture of xanthan gum in particular.
Patent NZ-233584-A (NZ)
Title: Mixing device for preparing a paste-like material with two cylinders separated by a breakable membrane
Inventor: KINDT-LARSEN TURE
IPC: A61B50/00
Filed: 1990-05-07
Abstract: A mixing device comprises a first cylinder (10) containing a particulate or powdered component (11) and having a closed first end (13, 14) and an opposite second end which is closed by a piston-like venting and filtering assembly (12, 15). The device also comprises a second cylinder (18) containing the liquid component (19) and having a closed end (20, 22) and an opposite open end sealingly receiving the closed end of the first cylinder (10) therein in a piston-like manner. Means (14) are provided for communicating the inner space of the first and second cylinders (10, 18) through the closed end (13, 14) of the first cylinder (10), when the first cylinder is forced into the second cylinder, whereby liquid from the first cylinder is injected into interstices defined between the particulate component contained in the first cylinder for providing a paste-like material. The communicating means is preferably formed by a breakable membrane (14). The venting and filtering assembly (12, 15) may be used as a piston for discharging the paste-like mixture made from the first cylinder (10). The mixing device is preferably used for mixing components so as to form a bone cement.
Patent NZ-238701-A (NZ)
Title: 2,4- and 2,5-substituted pyridine-n-oxides and pharmaceutical compositions
Inventor: BAADER EKKEHARD
IPC: A61P9/10
Filed: 1991-06-26
Abstract: 2,4- and 2,5-substituted pyridine N-oxides which have fibrosuppressive and immunosuppressive activity are presented. The said compounds are likewise suitable for the treatment of disturbances of the metabolism of collagen and collagen-like substances and of the biosynthesis of C1q.
Patent NZ-241584-A (NZ)
Title: 2- and/or 4-substituted thiazole and oxazole derivatives, preparation and pharmaceutical compositions thereof
Inventor: NOWAKOWSKI JOLANTA TERESA
IPC: A61K31/42
Filed: 1992-02-11
Abstract: Compounds of formula (I), wherein R1 is hydrogen, C1 to C6 alkyl, phenyl, benzyl, -COR4, or -SO2R4; R2 is (1), (2) or (3); R3 is -(CH2)d-Z; Z is (4); R4 is C1 to C6 alkyl, phenyl, or benzyl; R5 is hydrogen or C1 to C6 alkyl; R6, R7, R11, R12, and R13 are each independently hydrogen or C1 to C6 alkyl; either R8 or R9 is hydrogen, C1 to C6 alkyl, halogen-substituted C1 to C6 alkyl, 1-pyrrolidynylmethyl, 1-piperidynylmethyl, cyclopentylmethyl, cyclohexylmethyl or (5) with the other being the bond between R3 and Z; Q is (6) or (7).
Patent NZ-243783-A (NZ)
Title: 5-aminosulphonylisoquinoline derivatives and pharmaceutical compositions
Inventor: PEGLION JEAN-LOUIS
IPC: A61P11/00
Filed: 1992-07-30
Abstract: Compounds of formula (I):   <IMAGE> (I)   <IMAGE>  with R1, R2, U, X, Y, Z, n, m, p and r as defined in the description. Medicinal products.
Patent NZ-262893-A (NZ)
Title: Roller conveyor: roller shafts attached to rails mounted on flexible chain
Inventor: VOLDBY PER
IPC: B64F1/32
Filed: 1994-03-09
Abstract: PCT No. PCT/DK94/00102 Sec. 371 Date Sep. 18, 1995 Sec. 102(e) Date Sep. 18, 1995 PCT Filed Mar. 9, 1994 PCT Pub. No. WO94/21542 PCT Pub. Date Sep. 29, 1994A parcel conveyor having a number of rollers forming a supporting surface for the cargo to be transported is disclosed. The conveyor is divided into a number of separate roller/shaft units having the same shape which are linked together by a single, longitudinally rigid but sidewards flexible, driving device, such as a cardan chain. The units run on rollers on the floor and can be pushed or pulled centrally in a straight line or in a curve by way of the driving means. By use of such a conveyor, luggage can easily be transported on the cargo supporting rollers all the way to the end of the conveyor even as the conveyor is progressively pulled out of a cargo compartment as the cargo compartment is filled with luggage.
Patent NZ-265379-A (NZ)
Title: High speed battery charging by monitoring battery voltage and temperature
Inventor: SIMMONDS STEWART NEIL
IPC: H02J7/00
Filed: 1994-04-20
Abstract: PCT No. PCT/JP94/00651 Sec. 371 Date May 24, 1995 Sec. 102(e) Date May 24, 1995 PCT Filed Apr. 20, 1994 PCT Pub. No. WO95/09471 PCT Pub. Date Apr. 6, 1995To provide a single universal charging apparatus, capable of charging at high speed and efficiency any type of secondary battery, and capable of charging secondary batteries any arbitrary charging rate. In selecting the arbitrary amount of current from low current to high current while charging a variety of secondary batteries, the voltage and temperature of the battery are monitored, so that either at the point at which the rate of rise of the temperature of the battery exhibits an increase over the immediately previous rate of rise that exceeds a given reference value, or at the point at which the difference in change of battery voltage is decreased continuously for a preestablished amount of time, the charging of the battery is stopped.
Patent NZ-274229-A (NZ)
Title: Infusion packet; drawstrings held in peripheral heat seal with ends attached to tags
Inventor: KUIPERS JAN JACOB
IPC: B65D77/00
Filed: 1994-10-12
Abstract: Packets containing a flowable material are provided with a draw-string or thread to squeeze the packet contents. The packet envelope is formed from a doubled-over web which gives the packet a folded-over edge and which encloses an intermediate portion of the thread close to the folded-over edge. The end portions of the web extend from the intermediate portion of the thread to extend through the opposite edge of the packet. The external ends of the thread are secured to a tag which is attached to the outer face of the envelope. The thread intermediate portion is retained close to said one edge by heat seal means. Apparatus is also described for producing the packets in a continuous or semi-continuous manner.
Patent NZ-332569-A (NZ)
Title: A process for producing a percarbonate without the addition of a chloride salting out agent in which the dissolution step restricts the sodium carbonate to 60-90% of its saturated concentration at 35C
Inventor: JAMES ALUN PRYCE
IPC: C11D7/18
Filed: 1997-03-27
Abstract: A continuos process for the manufacture of sodium percarbonate in which hydrogen peroxide, sodium carbonate and an aqueous medium are introduced into a reaction vessel in which the hydrogen peroxide and sodium carbonate react.  The resultant sodium percarbonate precipitates out of solution, is separated from the mother liquor and recovered as product.  At least a fraction of the mother liquor, which inherently contains a residual amount of sodium carbonate in aqueous form is recycled to the reaction vessel. Particulate sodium carbonate is continually added to the process so that the ratio of Hydrogen peroxide to sodium carbonate in the reaction vessel is within the range of more that 0.7:1 and less than 1.3:1.  The temperature of the reaction is maintained within the range of 10 to 25oC thereby continuously forming and precipitating sodium percarbonate. The invention provides a process intended to be conducted without addition of chloride salting-out agent in which the dissolution step is controlled to restrict the sodium carbonate concentration to below 95 % of its saturated concentration at a temperature preferably controlled to at most 35 °C.  In some embodiments, at least a fraction of the mother liquor introduced into the dissolution tank is obtained by extraction from the reaction vessel.  In other embodiments a fraction of the sodium percarbonate is introduced in solution in the mother liquor and a fraction is introduced in particulate form directly into the reaction vessel. Large particle sodium percarbonate is provided which has a 7 day aged heat emission at 40 °C of not more than 3mW/g measured in a microcalorimeter over 16 hours that is lower than the heat emission from conventionally produced sodium percarbonate employing a chloride salting-out agent.
Patent NZ-332639-A (NZ)
Title: bleaching composition containing cyanopyridine N-oxide peroxide bleach activator and peroxide bleach
Inventor: REES WAYNE M
IPC: C11D3/395
Filed: 1997-05-05
Abstract: bleaching system that contains a peroxide and an activator is claimed. The activator is a cyanopyridine N-oxide and the peroxide is preferably hydrogen peroxide. When such bleaching systems are utilized in an aqueous alkaline environment, they provide bleaching performance on a variety of stains on both hard and soft surfaces.
Patent NZ-335629-A (NZ)
Title: Use of 1,3-propanediol derivatives for preventing or treating graft vessel disease
Inventor: COTTENS SYLVAIN
IPC: A61K39/395
Filed: 1997-11-17
Abstract: Compounds of formula I for preventing or treating graft vessel diseases in a recipient of organ or tissue allo- or xenotransplant, wherein: R1 is an optionally substituted straight or branched carbon chain having 12 to 22 carbon atoms which may be optionally interrupted by an optionally substituted phenylene; and R2, R3, R4 and R5 are independently H or lower alkyl.
Patent NZ-335977-A (NZ)
Title: Pyridine derivatives which are knoevenagel condensation products
Inventor: KESEL ANDREAS JOHANNES
IPC: C07F9/58
Filed: 1997-11-07
Abstract: The pyridine derivatives, their salts, hydrates or stereoisomers have the formula I wherein: X1, X2 and X3 are independently -O-, -S- or -NR5-; Y is -O- or -S-; Z is -CR5 or =N-; R1 to R5 are independently a substituent such as hydrogen, halo, hydroxy, amino, aminoalkyl, alkoxy or a substituent containing a group negatively charged under physiological conditions; R6 is an optionally substituted hydrocarbon or -O- and n is 0 or 1; provided that the compound is not pyridoxylidenerhodanine. A pharmaceutical composition thereof is useful for treating infectious diseases, tumours, autoimmune diseases or diseases associated with defects of the vitamin B metabolism, immune system or enzymatic reactions.
Patent NZ-337065-A (NZ)
Title: Medical aerosol formulations containing carbon dioxide, a hydrofluoroalkane, a cosolvent and a beta-mimetic / corticoid / anticholinergic / spasmolytic / analgesic agent
Inventor: KELLER MANFRED
IPC: A61K31/565
Filed: 1998-02-02
Abstract: A pressure-liquefied propellant mixture for aerosols, comprising a fluorinated alkane, in particular 1,1,1,2-tetrafluoroethane and/or 1,1,1,2,3,3,3-heptafluoropropane, and carbon dioxide, makes possible an improvement of the wetting properties of pharmaceutically active compounds, with which the formulation problems existing with hydrofluoroalkanes in relation to suspension as well as solution aerosols can be overcome and thus improved medicinal aerosol formulations can be obtained. With the aid of carbon dioxide, it is also possible to specifically influence the pressure and thus the particle size distribution and also by displacement of oxygen from the hydrofluoroalkanes to improve the storage stability of oxidation-sensitive active compounds.
Patent NZ-502377-A (NZ)
Title: Slot machine type game with feature outcome awarded on trigger condition, and testing facility for trigger
Inventor: OLIVE SCOTT
IPC: A63F13/12
Filed: 1998-07-08
Abstract: A plurality of electronic gaming machines (10) are connected to a network (11), to which a feature jackpot controller (12) and display means (13) are also connected. Each of the electronic gaming machines (10) are provided with a network interface arranged to provide a signal onto the network (11) on each occurrence of an operation of a respective machine and the jackpot controller (12) is arranged to receive each of the machine operation signals and to increment the value of a random jackpot prize on the occurrence of each of these operation signals. Prior to each game, the gaming machine (10) selects a random number from a range of numbers and during each game, the machine allocates the first n numbers in the range, where n is the number of credits bet by the player in that game. At the end of the game, the randomly selected number is compared with the numbers allocated to the player and if a match occurs the particular machine is switched into a feature game mode in which a jackpot game is played for all or part of the incremental jackpot prize.
Patent NZ-502856-A (NZ)
Title: Bulk conveying system and method of controlling a bulk conveying system based upon demand of a particular distribution unit of a series of units
Inventor: GOH ENG SOON
IPC: E04G21/16
Filed: 1998-08-19
Abstract: Bulk conveying system and method of controlling a bulk conveying system. A main conveying pipe (2) connected to the bulk outlet (12) of a main storage container (1) has a pump unit (21) for driving the bulk material through the main conveying pipe (2). A plurality of distribution pipes (3) are connected to the main conveying pipe (2) and equipped with a distribution valve (31) to be opened or closed. A plurality of distribution units (4) are connected to the main conveying pipe (2) through a corresponding one of the distribution pipes (3). Stock level detectors (43) detect whether or not the actual stock level in the distribution unit container (41) is equal to or falls below a predetermined minimum stock level and whether or not it is equal to a predetermined maximum stock level. A conveyance control system (5) controls the distribution valve (31) of each of the distribution pipes (3) and the pump unit (21) on the basis of the detected values.
Patent NZ-503901-A (NZ)
Title: Transgenic avians containing replication-defective retroviral vectors and methods for tissue specific synthesis of protein in eggs laid by the avian or female progeny thereof.
Inventor: MACARTHUR WILLIAM C
IPC: C12N5/06
Filed: 1997-06-06
Abstract: A transgenic avian comprising a transgene and control elements operatively-linked tot eh transgene.  The control elements direct the synthesis of the transgene product in the egg white of an egg laid by the transgenic avian or female progeny thereof.  Also disclosed is the method of producing the transgenic avian which comprises the steps of: a) making an opening in an avian egg which is not more than seven days old and which contains an embryo, so as to expose a blastoderm, b) microinjecting through the opening into an area in close proximity t o the blastoderm, a solution containing a replication-defective retroviral vector comprising a transgene and control elements operatively-linked and capable of directing the synthesis of the transgene product in egg yolk, wherein the control elements comprise a promoter, a 5' untranslated region, a signal sequence and uptake sequence, c) sealing the opening after microinjection, d) incubating the egg until the avian is hatched from the egg.
Patent NZ-505516-A (NZ)
Title: Use of ginkgo biloba ginkgolide extracts for treating drug dependency
Inventor: DRIEU KATY
IPC: A61K31/365
Filed: 1998-12-01
Abstract: Ginkgo biloba extract for the treatment of easing withdrawal of individuals dependant on substances engendering dependency and/or addiction The Ginkgo bilioba extract contains one or more compounds selected from flavanoids, terpenes, bilobalides and compounds of formula (I) wherein the variables are:  W, X, Y and Z are independently H, OH, linear or branched alkoxy or O-Gs radicals, Gs-OH representing a mono- or disaccharide, or one of their derivatives or analogues; wherein At least one of W, X, Y or Z is O-Gs radical.
Patent NZ-508169-A (NZ)
Title: Quinoline-aminomethyl-pyridyl derivatives with anti- helicobacter activity
Inventor: ZIMMERMANN PETER
IPC: C07D409/14
Filed: 1999-05-20
Abstract: Compounds of formula (I) are described, wherein the substituents are defined herein. The compounds are used in the manufacture of medicaments for the control of Helicobacter bacteria.
Patent NZ-512200-A (NZ)
Title: Recombinant nucleic acid vector comprising a sequence encoding a secretion signal peptide of cel1 of Arabidopsis thaliana
Inventor: SHOSEYOV ODED
IPC: A01H5/10
Filed: 1998-07-26
Abstract: A recombinant nucleic acid vector is provided comprising a nucleic acid sequence encoding a secretion signal peptide of cel1 of Arabidopsis thaliana and a second sequence encoding a cell wall modulation protein or polypeptide, such as endo-1,4-â-glucanase, or the polypeptides encoded by a Clostridium cellulovorans cbpA gene, Clostridium thermocellum CipA gene or any Cellulomonas fimi cellulase gene.
Patent NZ-513928-A (NZ)
Title: Seat for a reclining office chair
Inventor: PRINCE JONATHAN WILLIAM
IPC: A47C7/46
Filed: 2001-09-03
Abstract: In order to provide enhanced flexibility the rear of the seat portion has zones on either side of a center line which each have a pattern of "weakeners" arranged in a series of spaced sinuous lines 163, 164.
Patent NZ-515189-A (NZ)
Title: Derivatized porous silicon as a biomaterial to use as a material for componets in or on the surface of the human body
Inventor: CANHAM LEIGH TREVOR
IPC: A61L27/02
Filed: 2000-04-27
Abstract: A multiplayer mirror, which is adapted for operation in or on the surface of a human or animal body comprising a stack of alternating layers of derivatized porous silicon having a substantially monomolecular layer. The monomolecular layer comprises one or more organic groups that are covalently bonded by hydrosilylation to at least part of the surface of the porous silicon, the structure and composition of the derivatized porous silicon being such that it is suitable for use as a biomaterial. The derivatized porous silicon has a first porosity and refractive index and a second porosity and refractive index with the second refractive index being higher than the first. Preferably the porous silicon is derivatized mesoporous silicon. Also described are a biofiltration device and an immunoisolation device comprising the biofiltration device, which comprise the derivatized porous silicon filters. Methods of monitoring the body using the mirror or biofiltration device are disclosed.
Patent NZ-515649-A (NZ)
Title: Indolylpiperidine derivatives as antihistaminic and antiallergic agents
Inventor: PAGES SANTACANA LLUIS
IPC: C07D401/04
Filed: 2000-05-31
Abstract: A compound of formula (I), wherein: A1 represents an alkylene, alkyleneoxy, alkylenethio, alkanoyl or hydroxyalkylene group, A2 represents a single bond, an alkylene or alkenylene group, W represents a single bond or an optionally substituted phenylene or furanylene group, R1 represents a hydrogen, alkyl, alkenyl, alkynyl, alkoxyalkyl, alkenyloxyalkyl, alkynyloxyalkyl, alkoxy-alkoxyalkyl, or an optionally substituted phenylalkyl group, R2 represents a hydrogen, halogen, alkyl or alkoxy group, and R3 represents a carboxyl or tetrazolyl group. The compounds are used in the preparation of medicaments for use as antihistaminic or antiallergic agents.